James W. Peacock

Vancouver, BC V6H3Z6, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST.

CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST.

Journal: Cell genomics
Published: August 28, 2024

Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.

Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.

Journal: Scientific reports
Published: October 26, 2023

Dependency of Tamoxifen Sensitive and Resistant ER+ Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth.

Dependency of Tamoxifen Sensitive and Resistant ER+ Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth.

Journal: Cells
Published: May 05, 2023

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.

Journal: Endocrine-related cancer
Published: January 17, 2023

Targeting Semaphorin 3C in Prostate Cancer With Small Molecules.

Targeting Semaphorin 3C in Prostate Cancer With Small Molecules.

Journal: Journal of the Endocrine Society
Published: June 03, 2018

Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.

Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.

Journal: Cancer letters
Published: April 03, 2018

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

Journal: EMBO molecular medicine
Published: January 20, 2018

Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells.

Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells.

Journal: Scientific reports
Published: June 07, 2017

Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.

Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.

Journal: Oncotarget
Published: September 12, 2016
Showing 1-9 of 9

Last Updated: 09/26/2026